MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SX-3228

CAS No. : 156364-04-4

MCE 站：SX-3228

产品活性：SX-3228 是一种选择性苯二氮卓类 (benzodiazepine₁，BZ₁) 受体激动剂，IC₅₀ 为 17 nM。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling

作用靶点：GABA Receptor

In Vitro: SX-3228 is a selective ligand for the BZ1 receptor. Among the BZ-receptor subtypes, SX-3228 preferentially binds to the BZ1 receptor (IC₅₀=17 nM). It has very weak affinity for the BZ2 receptor (spinal cord: IC₅₀=127 nM), and virtually no affinity for the peripheral type BZ receptor (kidney: IC₅₀>10000 nM). A compound with similar selectivity, SX-3228 has been shown to bind to BZ receptors, but not to dopamine (D₁, D₂), serotonin (5-HT₁, 5-HT₂ and 5-HT₃ subtypes), noradrenaline (α₁, α₂, β), GABA or acetylcholine (muscarinic) subtypes.

In Vivo: Administration of 0.5-2.5 mg/kg SX-3228 to rats during the light phase induces a significant reduction of rapid-eye-movement sleep (REMS) (P<0.05) during the third recording hour. Administration of SX-3228 (0.5-2.5 mg/kg) at the beginning of the dark period significantly and dose-dependently reduces waking (W) and increases slow wave sleep (SWS) during the 6-h recording period (P<0.05-0.01); however, significant changes during the last recording hour are restricted to the 2.5 mg/kg dose (P<0.01).

相关产品：(+)-Bicuculline  |  Aminooxyacetic acid hemihydrochloride  |  Gabazine  |  Riluzole  |  γ-Aminobutyric acid  |  Picrotoxin  |  Propofol  |  Vigabatrin  |  (R)-Baclofen  |  CGP52432  |  Furosemide  |  Etomidate  |  Flumazenil  |  Dihydroergotoxine mesylate  |  Ginkgolide A  |  Methionine  |  Emamectin Benzoate  |  Etifoxine  |  Isoguvacine hydrochloride  |  Jujuboside A  |  Topiramate  |  Lotilaner  |  (-)-Securinine  |  alpha-Asarone  |  Clomethiazole  |  Acamprosate calcium  |  DMCM hydrochloride

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。